IP Library › Assignment 050257/0926
Patent Assignment
Reel/Frame 050257/0926

Assignment of Assignor's Interest

Recorded: 2019-09-03 Pages: 3
Assignor
SCHRÖDINGER, INC.
Executed: 2018-04-03
Assignee
SCHRÖDINGER, LLC
120 WEST 45TH STREET, TOWER 45, NEW YORK, NEW YORK, 10036-4041
Covered Property (1)
Inhibitors of (Alpha-V)(Beta-6) Integrin
Application: 16/489,646 →
Publication: US 2020/0002334
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger Sep 3, 2019
From: LAZULI, INC.
To: MORPHIC THERAPEUTIC, INC.
Reel/Frame 050247/0060 →
Assignment of Assignor's Interest Sep 3, 2019
From: GERASYUTO, ALEKSEY I.; KONZE, KYLE D.; SVENSSON, MATS A.
To: SCHRÖDINGER, INC.
Reel/Frame 050255/0083 →
Assignment of Assignor's Interest Sep 3, 2019
From: MORPHIC THERAPEUTIC, INC.
To: LAZULI, INC.
Reel/Frame 050255/0087 →
Assignment of Assignor's Interest Sep 3, 2019
From: SCHRÖDINGER, LLC
To: MORPHIC THERAPEUTIC, INC.
Reel/Frame 050255/0090 →
Assignment of Assignor's Interest Sep 3, 2019
From: HARRISON, BRYCE A.; BURSAVICH, MATTHEW G.; HAHN, KRISTOPHER N.; LIN, FU-YANG
To: MORPHIC THERAPEUTIC, INC.
Reel/Frame 050256/0438 →